Table:
begin	end	state
1	29	cytoplasmic
30	48	transmembrane
49	60	non-cytoplasmic
61	80	transmembrane
81	94	cytoplasmic
95	114	transmembrane
115	120	non-cytoplasmic
121	142	transmembrane
143	153	cytoplasmic
154	177	transmembrane
178	187	non-cytoplasmic
188	209	transmembrane
210	256	cytoplasmic
257	278	transmembrane
279	297	non-cytoplasmic
298	316	transmembrane
317	322	cytoplasmic
323	339	transmembrane
340	344	non-cytoplasmic
345	366	transmembrane
367	376	cytoplasmic
377	400	transmembrane
401	412	non-cytoplasmic
413	431	transmembrane
432	471	cytoplasmic

Input:
>AO356_25010 FitnessBrowser__pseudo5_N2C3_1:AO356_25010
MIGRHPLNNVTDSTHDSTLALAAAKVKRHVLPLVVVMFIVNYIDRVNIGFVRSHLETDLG
IGAAAYGLGAGLFFVGYALFEVPSNMLLQRYGARAWLTRIMFTWGAAAMAMAFVQGETSF
YVLRFILGAAEAGFFPGIIYYFTQWLPANERGKAMAIFLSGSAIASVISGPVSGALLHIS
GMGLHGWQWMFLIEGFASIVLCGFVWFWLQSHPSQAKWLTAEEKAVLIAAIAEEQRAREA
AQVIKPSMFKLLADRQIALFCFIYFSIALTIYGATFWLPSMIKKMGGLGDFQVGLLNSIP
WIISIVAMYGFAALAGKWKFQQAWVAVTLVIAAFGMFMSTTGGPIFAFVAICFAAIGFKA
ASALFWPIPQSYLDARVAAAVIALINSIGNLGGFVAPTAFGFLEQTTGSIEGGLYGLAAT
SLVAAVVIFFARTAPKRDTPNSLSGRPETVAEANQLEKSQALKPGPSGAAV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server